Technical Analysis of STOCKS & COMMODITIES
The Traders’ Magazine since 1982 has had over 1,226,237 subscribers from 174 different countries. 37,000 Page Traders’ Archive for $89.99
ARTICLE SYNOPSIS...Has Avigen peaked? The stock gained after an advisory committee of the U.S. National Institute of Health stated it would recommend the initiation of human clinical trials for Avigen's AV201, a gene therapy for advanced Parkinson's disease.